Nathan Pennell, MD, is a leading authority on the treatment of patients with lung cancer. He and colleagues at Cleveland Clinic are leading the development of new therapies, new treatment approaches, and new strategies to improve patient experience.
Dr. Pennell is a board certified medical oncologist who joined the staff of Cleveland Clinic's Taussig Cancer Center in 2008. He specializes in the treatment of thoracic malignancies with a focus on lung cancer, and was appointed Director of the TCI Lung Cancer Medical Oncology program in 2010. He is an Associate Professor of Medical Oncology at the Cleveland Clinic Lerner College.
Dr. Pennell's research interests include clinical trials using novel therapies, with a goal of facilitating the movement of new treatments from the laboratory to the clinic.